The short answer
A Botox consent form must identify the specific product and units, state the treatment areas, disclose material risks including the FDA boxed warning for distant spread of toxin effect, flag any off-label area, describe alternatives and the option of no treatment, set realistic onset and duration expectations, and record who performed the good faith exam and who injected.
What legal standard is the form actually being measured against?
Informed consent is judged against a disclosure standard, not against a form template. Roughly half the states follow the patient-centered "material risk" rule articulated in Canterbury v. Spence, which asks what a reasonable person in the patient's position would want to know before deciding. The remaining states apply a professional standard, asking what a reasonable practitioner in the community would disclose. Several states codify specific elements by statute or medical board rule.
Practically, both standards converge on the same content for cosmetic neuromodulators, because the patient is healthy, the procedure is elective, and the tolerance for undisclosed risk in elective cosmetic medicine is very low. A form that reads like a liability waiver rather than a disclosure fails both tests.
Which disclosures are specific to botulinum toxin?
Four items separate a real tox consent from a generic one.
The boxed warning. BOTOX, BOTOX Cosmetic and the other approved botulinum toxin products carry an FDA boxed warning for distant spread of toxin effect — symptoms such as swallowing and breathing difficulties, generalized weakness, blurred vision and ptosis that can occur hours to weeks after injection. The consent should state this in plain language and tell the patient to seek immediate care if it happens.
On-label versus off-label areas. BOTOX Cosmetic is FDA-approved for glabellar lines, lateral canthal lines and forehead lines in adults. Masseter slimming, the "lip flip," platysmal bands, gummy smile, hyperhidrosis outside the approved axillary indication, and neck or brow lift techniques are off-label. Off-label use is lawful medical practice, but a patient who was never told the use was off-label has a live informed-consent claim. Name the areas and label them.
Product identity and counterfeits. In April 2024 the FDA warned about counterfeit BOTOX found in multiple states, and the CDC issued Health Alert Network advisory HAN 00507 after 22 people across 11 states reported harmful reactions to counterfeit or mishandled botulinum toxin, with eleven hospitalized. The consent and the chart should name the exact product, manufacturer, lot number, expiration and units per area. This protects the patient and documents that you sourced from an authorized supplier.
Contraindications and screening. Known hypersensitivity, infection at the injection site, neuromuscular disorders such as myasthenia gravis, ALS or Lambert-Eaton, aminoglycoside use, pregnancy and breastfeeding, and prior toxin within the last three months.
What else belongs on the page?
| Element | Why it matters |
|---|---|
| Provider identity | Names both the examining prescriber and the injector |
| Alternatives | Fillers, energy devices, topical, and doing nothing |
| Onset and duration | Typically 3–7 days to onset, roughly 3–4 months of effect |
| Common effects | Bruising, headache, injection-site pain, asymmetry |
| Serious risks | Ptosis, diplopia, dysphagia, allergic reaction, antibody-mediated non-response |
| No guarantee clause | Explicit statement that no result is promised |
| Touch-up policy | Whether a two-week review is included and at what cost |
| Aftercare | Upright posture, avoid rubbing, exercise and heat guidance |
| Photography | Separate authorization if images will be used beyond the chart |
| Signature block | Patient, witness where used, provider, date and time |
What this means for your paperwork
The consent form is one of three documents that must agree with each other. The good faith exam note establishes that a lawful prescriber evaluated the patient and found a medical indication. The patient-specific order states the product, units and areas ordered. The consent shows the patient understood and agreed to exactly that. If the order says 20 units glabellar and the chart shows 44 units across three areas including a masseter, the consent will not save you.
Re-sign the consent for each treatment session rather than relying on one signature from two years ago, and update the health history each visit. Record lot and expiration in the chart every time, and keep a written product-sourcing policy in your procedures manual naming your authorized distributor.
Related questions
This answer is educational and is not legal or medical advice. Requirements vary by state and change over time — verify with your own legal and clinical advisors before applying anything here in practice.